BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2776830)

  • 1. Characterization of contractile prostanoid receptors on human airway smooth muscle.
    Armour CL; Johnson PR; Alfredson ML; Black JL
    Eur J Pharmacol; 1989 Jun; 165(2-3):215-22. PubMed ID: 2776830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction.
    Beasley RC; Featherstone RL; Church MK; Rafferty P; Varley JG; Harris A; Robinson C; Holgate ST
    J Appl Physiol (1985); 1989 Apr; 66(4):1685-93. PubMed ID: 2525122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostanoid-induced contraction of human bronchial smooth muscle is mediated by TP-receptors.
    Coleman RA; Sheldrick RL
    Br J Pharmacol; 1989 Mar; 96(3):688-92. PubMed ID: 2720298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder.
    Palea S; Toson G; Pietra C; Trist DG; Artibani W; Romano O; Corsi M
    Br J Pharmacol; 1998 Jul; 124(5):865-72. PubMed ID: 9692770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for thromboxane receptor mediated contraction of guinea-pig and human airways in vitro by prostaglandin (PG) D2, 9 alpha,11 beta-PGF2 and PGF2 alpha.
    Featherstone RL; Robinson C; Holgate ST; Church MK
    Naunyn Schmiedebergs Arch Pharmacol; 1990 May; 341(5):439-43. PubMed ID: 2142256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of contraction-mediating prostanoid receptors in human hand veins: effects of the thromboxane receptor antagonists BM13,505 and AH23848.
    Arner M; Högestätt ED; Uski TK
    Acta Physiol Scand; 1991 Jan; 141(1):79-86. PubMed ID: 2053448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the prostaglandin E2 sensitive (EP)-receptor in the rat isolated trachea.
    Lydford SJ; McKechnie K
    Br J Pharmacol; 1994 May; 112(1):133-6. PubMed ID: 8032634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional differences in the prostanoid receptors mediating prostaglandin F2 alpha-induced contractions of cat isolated arteries.
    Nakajima M; Ueda M
    Eur J Pharmacol; 1990 Dec; 191(3):359-68. PubMed ID: 2086248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of LTE4-induced histamine hyperresponsiveness in guinea-pig tracheal and human bronchial smooth muscle, in vitro.
    Jacques CA; Spur BW; Johnson M; Lee TH
    Br J Pharmacol; 1991 Dec; 104(4):859-66. PubMed ID: 1667288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery.
    Lydford SJ; McKechnie KC; Dougall IG
    Br J Pharmacol; 1996 Jan; 117(1):13-20. PubMed ID: 8825337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
    Lumley P; White BP; Humphrey PP
    Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a dilator function of 8-iso prostaglandin F2 alpha in rat pulmonary artery.
    Jourdan KB; Evans TW; Curzen NP; Mitchell JA
    Br J Pharmacol; 1997 Apr; 120(7):1280-5. PubMed ID: 9105703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAY u3405, a potent and selective thromboxane A2 receptor antagonist on airway smooth muscle in vitro.
    McKenniff MG; Norman P; Cuthbert NJ; Gardiner PJ
    Br J Pharmacol; 1991 Nov; 104(3):585-90. PubMed ID: 1839139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the new thromboxane A2 antagonist vapiprost on isolated canine blood vessels.
    Matsuzaki T; Noguchi K; Nakasone J; Uezu K; Higuchi M; Sakanashi M
    Arzneimittelforschung; 1992 Nov; 42(11):1318-22. PubMed ID: 1492844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of thromboxane A2 in bradykinin-induced human isolated small bronchi contraction.
    Molimard M; Martin CA; Naline E; Hirsch A; Advenier C
    Eur J Pharmacol; 1995 May; 278(1):49-54. PubMed ID: 7545124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of thromboxane A2 antagonist GR32191B on prostanoid and nonprostanoid receptors in the human internal mammary artery.
    He GW; Yang CQ
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):13-9. PubMed ID: 7564353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
    Watts IS; Wharton KA; White BP; Lumley P
    Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contractile effects of prostanoids on fetal rabbit ductus arteriosus.
    Smith GC; McGrath JC
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):113-8. PubMed ID: 7723339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel inhibitory prostanoid receptor in piglet saphenous vein.
    Coleman RA; Grix SP; Head SA; Louttit JB; Mallett A; Sheldrick RL
    Prostaglandins; 1994 Feb; 47(2):151-68. PubMed ID: 8016385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitory effects of AA-2414, a thromboxane (Tx) A2 receptor antagonist, on U-46619-, prostaglandin (PG) D2- and 9 alpha, 11 beta PGF2-induced contractions of guinea pig tracheas and isolated human bronchi].
    Itoh Y; Shindoh J; Horiba M; Kohno S; Ohata K; Ashida Y; Takagi K
    Arerugi; 1993 Nov; 42(11):1670-6. PubMed ID: 8279967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.